| Drug Name |
Thioridazine |
| Drug ID |
BADD_D02200 |
| Description |
A phenothiazine antipsychotic used in the management of psychoses, including schizophrenia, and in the control of severely disturbed or agitated behavior. It has little antiemetic activity. Thioridazine has a higher incidence of antimuscarinic effects, but a lower incidence of extrapyramidal symptoms, than chlorpromazine. (From Martindale, The Extra Pharmacopoeia, 30th ed, p618).
Thioridazine was withdrawn worldwide in 2005 due to its association with cardiac arrythmias. |
| Indications and Usage |
For the treatment of schizophrenia and generalized anxiety disorder. |
| Marketing Status |
approved; withdrawn |
| ATC Code |
N05AC02 |
| DrugBank ID |
DB00679
|
| KEGG ID |
D00373
|
| MeSH ID |
D013881
|
| PubChem ID |
5452
|
| TTD Drug ID |
D0U1OE
|
| NDC Product Code |
Not Available |
| UNII |
N3D6TG58NI
|
| Synonyms |
Thioridazine | Thioridazine Hydrochloride | Thioridazine HCL | Thioridazine-Neurazpharm | Thioridazine Neurazpharm | ThioridazineNeurazpharm | Thiozine | Aldazine | Meleril | Mellaril | Melleril | Melleryl | Melleretten | Melzine | Rideril | Sonapax | Apo-Thioridazine | Apo Thioridazine | ApoThioridazine |
